Neumora Therapeutics, Inc. - Common Stock — Quarterly Cash Flow (NASDAQ:NMRA) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 316.97 M256.75 M223.82 M177.83 M191.05 M153.88 M Total liabilities 29.91 M28.38 M40.95 M45.67 M87.18 M83.2 M Total equity 287.06 M228.36 M182.88 M132.16 M103.87 M70.68 M Total liabilities & shareholders' equities 316.97 M256.75 M223.82 M177.83 M191.05 M153.88 M Total debt ——39.45 M39.56 M114.53 M112.96 M Net debt ——-198.14 M-151.96 M-128 M-34.11 M

News

SoftBank Just Dumped Circle Stock. Don’t Panic and Keep Adding CRCL Here.

Neumora Therapeutics: Downgrading After Navacaprant Development Setback (NASDAQ:NMRA)

Neumora Therapeutics, Inc. (NMRA) Q4 2025 Earnings Call Transcript

Neumora Therapeutics CFO Milligan sells $5119 in shares

Neumora Therapeutics, Inc. (NMRA) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 - Slideshow (NASDAQ:NMRA) 2026-02-12

Intel, Wells Fargo among market cap stock movers on Tuesday

Oracle, Palantir among market cap stock movers on Monday

BioAge Rockets As It Takes On Eli Lilly's Takeover Play, Ventyx Bio

Leerink Partners initiates coverage on Neumora stock with Outperform rating

Mizuho reiterates Outperform rating on Neumora Therapeutics stock

Eli Lilly and Regencell among market cap stock movers on Wednesday

Eli Lilly and Intel lead market cap stock movers on Wednesday